Trials / Unknown
UnknownNCT02675010
Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study
Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Multicenter Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
There are controversies about the best sites -biopsy based -tests for H pylori associated gastritis. The study is designed to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia.
Detailed description
. The study is designed to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia. 400 patients with dyspepsia are planned to be enrolled in this study. in addition to the routine antral biospy, corpus biospies are taken to evaluate the optimal site of gastric mucosal biopsy for identification of Helicobacter pylori, especially in case of gastric atrophy and/or intestinal metaplasia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY | ENDOSCOPIC GASTRIC BIOPSIES FROM ANTRUM AND BODY |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2016-02-05
- Last updated
- 2016-03-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02675010. Inclusion in this directory is not an endorsement.